Skip to content

Comparison of the Impact of Three Programs of Inspiratory Muscles.

Comparison of the Incidence of 3 Inspiratory Muscle Training Programs on Inspiratory Strength, on Difficult to Wean Patients in Intensive Care Unit: a Multi-centre Randomised Trial.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02855619
Acronym
PREDRIC
Enrollment
92
Registered
2016-08-04
Start date
2016-10-15
Completion date
2020-03-22
Last updated
2026-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Weaning From Mechanical Ventilation

Keywords

inspiratory muscles training programs, Ventilator-induced diaphragmatic dysfunction, Weaning, Intensive care unit

Brief summary

Ventilator-induced diaphragmatic dysfunction appears to contribute to slow weaning from mechanical ventilation. Several trials of inspiratory muscle training to facilitate weaning in intensive care have been performed, with inconsistent results, utilizing different methods of IMT in different populations. In this study, the investigators want to compare the incidence of 3 inspiratory muscle training programs on inspiratory strength, on difficult to wean patients in intensive care unit. This is a multi-center randomized trial not blinded with 3 parallels groups: * Martin's group: a threshold-based IMT is performed like used by Martin in a randomized trial in 2011, in a view of inspiratory strength increase. * Cader's group: a threshold-based IMT is performed like used by Cader in a randomized trial in 2010 , in a view of inspiratory endurance increase. * EDRIC's group: a new treshold-based IMT is performed, in a view of both inspiratory strength and endurance increase. The investigators think that a new threshold-based IMT performed in a view of both inspiratory strength and endurance increase, is more effective and well tolerated than the 2 others protocols.

Detailed description

The main objective of this study is to determinate which IMT program is the most effective on the inspiratory muscle strength and endurance increase. The investigators will be able to study the impact on the weaning time of IMT performed with the best protocol. The investigators are going to conduct a randomized trial with intention-to-treat analysis. Following 18h of invasive mechanical ventilation in a controlled mode, the failure of the first single breathe trial of 2 hours and the presence of sevrability criterias defined by the European consensus conference in 2007, 88 participants will be included. Participants will be randomizesd to receive one of the 3 protocols of IMT, 2 times per day, 7 days per week, from the inclusion to the extubation. The ratio of randomization will be 1:1:2 for a better evaluation of EDRIC's group wich propose a new IMT protocol.

Interventions

PROCEDUREMartin

The physiotherapist perform the IMT using the threshold IMT inspiratory muscle trainer, connected to the intubation tube. He manage the resistance to the higher resistance tolerated by the patient in a set of 6 breaths. Participant repeats 4 sets of 6-10 breaths with 2 minutes of resting with mechanical ventilation between each set. This treatment is made twice a day, 7days per week from inclusion to extubation exept if Glasgow score is under 8, hyperthermia more than 39°c, haemodynamic's instability, or hypoxemia( PaO2/FiO2\<150).

PROCEDURECader

The physiotherapist perform the IMT using the threshold IMT inspiratory muscle trainer, connected to the intubation tube. He manage the resistance to 30% of the Maximal Inspiratory Pressure initially recorded the day of the inclusion. Participant breaths against this resistance during 5 minutes. The resistance is daily increased of 10 % to the higher tolerated. This treatment is made twice a day, 7days per week from inclusion to extubation exept if Glasgow score is under 8, hyperthermia more than 39°c, haemodynamic's instability, or hypoxemia( PaO2/FiO2\<150).

PROCEDUREEDRIC

The physiotherapist perform the IMT using the threshold IMT inspiratory muscle trainer, connected to the intubation tube. He manage the resistance at 30% of the Maximal Inspiratory Pressure of the day for the first set of 20 breaths with a resistance 's increasment of 10% at each set. Participant repeats 4 sets of 20 breaths with 2 minutes of resting with mechanical ventilation between each set. This treatment is made twice a day, 7days per week from inclusion to extubation exept if Glasgow score is under 8, hyperthermia more than 39°c, haemodynamic's instability, or hypoxemia( PaO2/FiO2\<150).

Sponsors

University Hospital, Bordeaux
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient ventilated more than 18h in a controlled mode; * First single breathe trial of 2 hours failure; * Presence of sevrability criterias definied by the European consensus conference in 2007 an usually used: * diminution of the sedfative agents, * Patients with spontaneous beath in VAC mode or patient ventilated in a VSAI-PEP mode, * PaO2/FiO2 ≥150, * Absence d'inotropes ou de vasopresseurs à forte dose ou dose croissante (\<1mg/h), * SaO2 \> 90% with FiO2 ≤ 50%, * PEP ≤ 8cmH2O, * Corporal température between 36°C and 39°C, * Glasgow Score ≥ 8.

Exclusion criteria

* Age \< 18 years ; * medically unstable; * Poor vital pronostic at very short term; * Cardiac arrest with a poor neurological prognostic; * Neuromuscular disease ; * Pneumothorax non drained ; * Tracheostomy ; * Current pregnancy ; * Patients with guardianship or trusteeship.

Design outcomes

Primary

MeasureTime frame
Maximal Inspiratory Pressure score (inspiratory muscle strength index) performed by an external electronic device connected with a unidirectional valve.Baseline and up to day 25

Secondary

MeasureTime frame
Peak Pressure (inspiratory muscle endurance index) performed by an incremental threshold test.Baseline and up to day 25
Duration of the weaning periodup to day 25
ICU lengh of stayDay 30
Weaning successup to day 27
Adverse eventsDay 30

Countries

France

Contacts

STUDY_CHAIRPaul Perez, Professor

University Hospital, Bordeaux

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 1, 2026